Can a Nomogram Predict Survival After Treatment for an Ankylosing Spondylitis Cervical Fracture in a Patient With Neurologic Impairment? A National, Multicenter Study

医学 列线图 强直性脊柱炎 外科 回顾性队列研究 内科学
作者
Hao Bai,Yaobin Li,Xinyi Huang,Quanchang Tan,Xuexiao Ma,Qingde Wang,Linfeng Wang,Xiongsheng Chen,Bing Wang,Liangbi Xiang,Hao Liu,Xiaomin Ma,Xinyu Liu,Zhensong Jiang,Aimin Wu,Weidong Cai,Peng Liu,Ningfang Mao,Ming Lu,Yong Wan,Xiaofang Zang,Songkai Li,Bo Liao,Shuai Zhao,Suochao Fu,Youzhuan Xie,Haiyang Yu,Ruoxian Song,Zhen-Sheng Ma,Ming Yan,Jianjun Chu,Jiangbo Sun,Xiang Liu,Yafei Feng,Yuan Dong,Dingjun Hao,Wei Lei,Zixiang Wu
出处
期刊:Clinical Orthopaedics and Related Research [Lippincott Williams & Wilkins]
卷期号:481 (7): 1399-1411 被引量:2
标识
DOI:10.1097/corr.0000000000002542
摘要

Abstract Background Ankylosing spondylitis–related cervical spine fracture with neurologic impairment (ASCF-NI) is a rare but often lethal injury. Factors independently associated with survival after treatment remain poorly defined, and identifying patients who are likely to survive the injury remains challenging. Questions/purposes (1) What factors are independently associated with survival after treatment among patients with ASCF-NI? (2) Can a nomogram be developed that is sufficiently simple for clinicians to use that can identify patients who are the most likely to survive after injury? Methods This retrospective study was conducted based on a multi-institutional group of patients admitted and treated at one of 29 tertiary hospitals in China between March 1, 2003, and July 31, 2019. A total of 363 patients with a mean age of 53 ± 12 years were eventually included, 343 of whom were male. According to the National Household Registration Management System, 17% (61 of 363) died within 5 years of injury. Patients were treated using nonsurgical treatment or surgery, including procedures using the anterior approach, posterior approach, or combined anterior and posterior approaches. Indications for surgery included three-column injury, unstable fracture displacement, neurologic impairment or continuous progress, and intervertebral disc incarceration. By contrast, patients generally received nonsurgical treatment when they had a relatively stable fracture or medical conditions that did not tolerate surgery. Demographic, clinical, and treatment data were collected. The primary study goal was to identify which factors are independently associated with death within 5 years of injury, and the secondary goal was the development of a clinically applicable nomogram. We developed a multivariable Cox hazards regression model, and independent risk factors were defined by backward stepwise selection with the Akaike information criterion. We used these factors to create a nomogram using a multivariate Cox proportional hazards regression analysis. Results After controlling for potentially confounding variables, we found the following factors were independently associated with a lower likelihood of survival after injury: lower fracture site, more-severe peri-injury complications, poorer American Spinal Injury Association (ASIA) Impairment Scale, and treatment methods. We found that a C5 to C7 or T1 fracture (ref: C1 to C4 and 5; hazard ratio 1.7 [95% confidence interval 0.9 to 3.5]; p = 0.12), moderate peri-injury complications (ref: absence of or mild complications; HR 6.0 [95% CI 2.3 to 16.0]; p < 0.001), severe peri-injury complications (ref: absence of or mild complications; HR 30.0 [95% CI 11.5 to 78.3]; p < 0.001), ASIA Grade A (ref: ASIA Grade D; HR 2.8 [95% CI 1.1 to 7.0]; p = 0.03), anterior approach (ref: nonsurgical treatment; HR 0.5 [95% CI 0.2 to 1.0]; p = 0.04), posterior approach (ref: nonsurgical treatment; HR 0.4 [95% CI 0.2 to 0.8]; p = 0.006), and combined anterior and posterior approach (ref: nonsurgical treatment; HR 0.4 [95% CI 0.2 to 0.9]; p = 0.02) were associated with survival. Based on these factors, a nomogram was developed to predict the survival of patients with ASCF-NI after treatment. Tests revealed that the developed nomogram had good performance (C statistic of 0.91). Conclusion The nomogram developed in this study will allow us to classify patients with different mortality risk levels into groups. This, coupled with the factors we identified, was independently associated with survival, and can be used to guide more appropriate treatment and care strategies for patients with ASCF-NI. Level of Evidence Level III, therapeutic study
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
岁岁完成签到 ,获得积分10
1秒前
2秒前
慢慢完成签到,获得积分10
2秒前
境屾发布了新的文献求助30
2秒前
不安灵竹发布了新的文献求助10
4秒前
zqh发布了新的文献求助10
5秒前
冯心雨完成签到,获得积分10
5秒前
Boyce发布了新的文献求助10
6秒前
7秒前
bono完成签到 ,获得积分10
8秒前
董春伟完成签到,获得积分10
8秒前
9秒前
机灵雨南发布了新的文献求助10
9秒前
刘某发布了新的文献求助10
11秒前
从容面包关注了科研通微信公众号
11秒前
健壮的花瓣完成签到 ,获得积分10
12秒前
11完成签到,获得积分10
13秒前
13秒前
15秒前
Ithesleepyhead完成签到 ,获得积分10
15秒前
Hello应助溜溜小雁子采纳,获得10
16秒前
核桃发布了新的文献求助10
16秒前
如初发布了新的文献求助10
16秒前
量子星尘发布了新的文献求助10
16秒前
11111完成签到 ,获得积分10
18秒前
热爱完成签到,获得积分10
19秒前
黒子鳥关注了科研通微信公众号
19秒前
科研通AI6应助谦让的博采纳,获得10
19秒前
20秒前
互助遵法尚德完成签到,获得积分0
21秒前
七个丸子应助刘某采纳,获得10
21秒前
爱吃橙子完成签到 ,获得积分10
22秒前
22秒前
科研通AI2S应助11采纳,获得10
22秒前
浮游应助小卷心菜采纳,获得10
22秒前
24秒前
arthur完成签到,获得积分10
24秒前
26秒前
你我山巅自相逢完成签到 ,获得积分10
26秒前
放松的AI完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5069566
求助须知:如何正确求助?哪些是违规求助? 4290887
关于积分的说明 13368927
捐赠科研通 4111055
什么是DOI,文献DOI怎么找? 2251251
邀请新用户注册赠送积分活动 1256459
关于科研通互助平台的介绍 1188939